Mycotopia Therapies Inc Watch

EX-10.1

from 8-K 4 pages Exchange Agreement

12/34/56

EX-10.2

from 8-K 3 pages Intellectual Property Assignment

12/34/56

EX-10.1

from 8-K 19 pages Asset Sale and Purchase Agreement

12/34/56

EX-10.1

from 8-K 6 pages Termination of Agreement and Plan of Merger

12/34/56

EX-10.1

from 8-K 113 pages Agreement and Plan of Merger by and Among Psly.com, Inc. (“Parent”), Mycotopia Therapies Inc. (“Mti”), Silly Merger Sub M Inc. (“Merger Sub M”), Silly Merger Sub E Inc. (“Merger Sub E”), and EI.VENTURES, Inc. (“Evi”) Dated as of May ___, 2022

12/34/56

EX-10.1

from 8-K 13 pages Executive Consulting Agreement

12/34/56

EX-10.06

from 8-K 2 pages Amendment to Escrow Agreement and Definitive Agreements

12/34/56

EX-10.05

from 8-K 4 pages Change of Control and Funding Agreement

12/34/56

EX-10.04

from 8-K 8 pages Stock Purchase Agreement

12/34/56

EX-10.03

from 10-12G 30 pages Supplier Authorization Agreement-Produce U.S

12/34/56

EX-10.02

from 10-12G 6 pages Produce Fixed Term Purchase Agreement

12/34/56

EX-10.01

from 10-12G 11 pages Agreement for Purchase of Markon Branded and Brand Approved Product

12/34/56

EX-10.03

from 10-12G 30 pages Supplier Authorization Agreement-Produce U.S

12/34/56

EX-10.02

from 10-12G 6 pages Produce Fixed Term Purchase Agreement

12/34/56

EX-10.01

from 10-12G 11 pages Agreement for Purchase of Markon Branded and Brand Approved Product

12/34/56